Logo image of LILAK

LIBERTY LATIN AMERIC-CL C (LILAK) Stock Fundamental Analysis

NASDAQ:LILAK - Nasdaq - BMG9001E1286 - Common Stock - Currency: USD

6.89  +0.11 (+1.62%)

After market: 6.9 +0.01 (+0.15%)

Fundamental Rating

3

Taking everything into account, LILAK scores 3 out of 10 in our fundamental rating. LILAK was compared to 32 industry peers in the Diversified Telecommunication Services industry. LILAK may be in some trouble as it scores bad on both profitability and health. LILAK has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year LILAK has reported negative net income.
LILAK had a positive operating cash flow in the past year.
In the past 5 years LILAK always reported negative net income.
Of the past 5 years LILAK 4 years had a positive operating cash flow.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

1.2 Ratios

LILAK has a worse Return On Assets (-4.57%) than 70.97% of its industry peers.
LILAK has a worse Return On Equity (-47.42%) than 83.87% of its industry peers.
LILAK's Return On Invested Capital of 3.63% is in line compared to the rest of the industry. LILAK outperforms 54.84% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LILAK is in line with the industry average of 5.44%.
Industry RankSector Rank
ROA -4.57%
ROE -47.42%
ROIC 3.63%
ROA(3y)-1.56%
ROA(5y)-1.99%
ROE(3y)-11.02%
ROE(5y)-12.56%
ROIC(3y)4.37%
ROIC(5y)3.87%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

LILAK's Operating Margin of 11.09% is fine compared to the rest of the industry. LILAK outperforms 64.52% of its industry peers.
In the last couple of years the Operating Margin of LILAK has declined.
LILAK has a better Gross Margin (77.68%) than 96.77% of its industry peers.
LILAK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.09%
PM (TTM) N/A
GM 77.68%
OM growth 3Y3.14%
OM growth 5Y-2.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.36%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LILAK is destroying value.
There is no outstanding debt for LILAK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.19, we must say that LILAK is in the distress zone and has some risk of bankruptcy.
LILAK has a worse Altman-Z score (0.19) than 77.42% of its industry peers.
The Debt to FCF ratio of LILAK is 38.95, which is on the high side as it means it would take LILAK, 38.95 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LILAK (38.95) is comparable to the rest of the industry.
A Debt/Equity ratio of 6.20 is on the high side and indicates that LILAK has dependencies on debt financing.
LILAK has a Debt to Equity ratio of 6.20. This is amonst the worse of the industry: LILAK underperforms 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.2
Debt/FCF 38.95
Altman-Z 0.19
ROIC/WACC0.54
WACC6.7%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.06 indicates that LILAK should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.06, LILAK is in line with its industry, outperforming 45.16% of the companies in the same industry.
A Quick Ratio of 1.06 indicates that LILAK should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.06, LILAK perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for LILAK have decreased strongly by -1236.00% in the last year.
EPS 1Y (TTM)-1236%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.14%

3.2 Future

The Earnings Per Share is expected to grow by 51.43% on average over the next years. This is a very strong growth
Based on estimates for the next years, LILAK will show a small growth in Revenue. The Revenue will grow by 2.74% on average per year.
EPS Next Y111.24%
EPS Next 2Y51.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.18%
Revenue Next 2Y2.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 18.35, the valuation of LILAK can be described as rather expensive.
Based on the Price/Forward Earnings ratio, LILAK is valued a bit cheaper than the industry average as 67.74% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.68. LILAK is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 18.35
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LILAK is valued cheaply inside the industry as 87.10% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, LILAK is valued cheaper than 80.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.47
EV/EBITDA 5.84
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LILAK's earnings are expected to grow with 51.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.43%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LILAK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (2/21/2025, 8:00:02 PM)

After market: 6.9 +0.01 (+0.15%)

6.89

+0.11 (+1.62%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-05 2025-05-05
Inst Owners66.28%
Inst Owner Change-93.99%
Ins Owners10.17%
Ins Owner ChangeN/A
Market Cap1.36B
Analysts74.55
Price Target9.69 (40.64%)
Short Float %11.31%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19723.6%
Min EPS beat(2)-28858.2%
Max EPS beat(2)-10589%
EPS beat(4)1
Avg EPS beat(4)-10155.9%
Min EPS beat(4)-28858.2%
Max EPS beat(4)100%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.29%
Min Revenue beat(2)-5.29%
Max Revenue beat(2)-3.29%
Revenue beat(4)0
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)-2.79%
Revenue beat(8)0
Avg Revenue beat(8)-3.72%
Revenue beat(12)1
Avg Revenue beat(12)-2.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.56%
PT rev (1m)-0.1%
PT rev (3m)-7.33%
EPS NQ rev (1m)-33.15%
EPS NQ rev (3m)-33.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-8275%
Revenue NQ rev (1m)-0.94%
Revenue NQ rev (3m)-0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.35
P/S 0.3
P/FCF 6.47
P/OCF 1.81
P/B 1.1
P/tB N/A
EV/EBITDA 5.84
EPS(TTM)-3.34
EYN/A
EPS(NY)0.38
Fwd EY5.45%
FCF(TTM)1.06
FCFY15.45%
OCF(TTM)3.8
OCFY55.21%
SpS22.73
BVpS6.24
TBVpS-20.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -47.42%
ROCE 4.6%
ROIC 3.63%
ROICexc 3.84%
ROICexgc 7.9%
OM 11.09%
PM (TTM) N/A
GM 77.68%
FCFM 4.68%
ROA(3y)-1.56%
ROA(5y)-1.99%
ROE(3y)-11.02%
ROE(5y)-12.56%
ROIC(3y)4.37%
ROIC(5y)3.87%
ROICexc(3y)4.72%
ROICexc(5y)4.19%
ROICexgc(3y)9.74%
ROICexgc(5y)8.86%
ROCE(3y)5.53%
ROCE(5y)4.9%
ROICexcg growth 3Y12.42%
ROICexcg growth 5Y-0.59%
ROICexc growth 3Y15.97%
ROICexc growth 5Y3.02%
OM growth 3Y3.14%
OM growth 5Y-2.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.36%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 6.2
Debt/FCF 38.95
Debt/EBITDA 4.98
Cap/Depr 52.18%
Cap/Sales 12.05%
Interest Coverage 0.84
Cash Conversion 48.95%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 0.19
F-Score6
WACC6.7%
ROIC/WACC0.54
Cap/Depr(3y)68.94%
Cap/Depr(5y)67.26%
Cap/Sales(3y)13.99%
Cap/Sales(5y)14.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1236%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y111.24%
EPS Next 2Y51.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.14%
Revenue Next Year3.18%
Revenue Next 2Y2.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.49%
EBIT growth 3Y9.38%
EBIT growth 5Y1.64%
EBIT Next Year184.28%
EBIT Next 3Y47.96%
EBIT Next 5YN/A
FCF growth 1Y107.53%
FCF growth 3Y61.33%
FCF growth 5Y50.51%
OCF growth 1Y-5.32%
OCF growth 3Y11.9%
OCF growth 5Y1.89%